Agenda

DxA Investigator Day 2024

The full-day symposium will be broken into a morning and afternoon session that features presentations by DxA-funded investigators, two panels convening industry experts, a poster session, and a lightning round.

Breakfast and lunch will be served. Coffee and refreshments will be available throughout the day.

All Sessions

Morning Session

8:00 –
8:30 am

Breakfast/Poster Session

Registration Location:

Level 1 | Auditorium II

8:30 –
8:45 am

Opening Remarks

Niranjan Bose, PhD, MS, B Pharm (Gates Ventures)
Howard Fillit, MD (ADDF)
Mark Roithmayr (ADDF)

8:45 –
9:15 am

Keynote: Update on Blood-Based Biomarkers for Alzheimer's Disease

Henrik Zetterberg, MD, PhD (University of Gothenburg)

9:15 –
9:25 am

Overview of DxA Portfolio

Laura Nisenbaum, PhD, MS (ADDF)

9:25 –
10:10 am

Panel: The Future of Alzheimer's Diagnostics in Clinical Care

Moderator: Niranjan Bose, PhD, MS, B Pharm (Gates Ventures)

Panelists:
Nicholas Ashton, PhD (University of Gothenburg)
Rhoda Au, PhD, MBA (Boston University)
Joel Braunstein, MD, MBA (C2N)
Dilraj Grewal, MD (Duke University)
Joseph Volpe, PhD (Labcorp)
Howard Fillit, MD (ADDF)

10:10 –
10:25 am

Coffee Break

10:25 –
10:45 am

To pTau217, or (Not) to pTau181, That Is the Question

Manu Vandijck (Fujirebio Europe NV)

10:45 –
11:05 am

Clinical Implementation of the ALZpath pTau217 Test, ALZpath Dx

Andreas Jeromin, PhD (ALZPath)

11:05 –
11:25 am

Novel Blood-Based Mitochondrial Biomarkers for the Prognosis of Progression from MCI to Alzheimer's Disease

Marta Barrachina, PhD, MBA (ADmit Therapeutics)

11:25 –
12:25 pm

Networking Luncheon

Lunch will be served

Afternoon Session

12:25 –
12:45 pm

Validation of the ki:elements Speech Biomarker for Cognition (SB-C) in Alzheimer’s Disease

Nicklas Linz, PhD (ki:elements)

12:45 –
1:05 pm

Digitally-Driven Precision Medicine: Accurate Identification of Preclinical and Prodromal Alzheimer’s & Measuring the Progression of MCI

Mylea Charvat, PhD (Altoida)
Marc Jones, MS (Altoida)
Ioannis Tarnanas, PhD (Altoida)

1:05 –
1:25 pm

Smartphone-Based Learning and Memory Assessment: Assessing Community Engagement in the Lila App

Svenja Wacker, PhD (Cogstate)

1:25 –
2:10 pm

Panel: Methods and Standardization

Moderator: Robert Dean, MD, PhD (Dean Consulting)

Panelists:
Kaj Blennow, MD, PhD (University of Gothenburg)
Jeffrey Dage, PhD (Indiana University)
Charlotte Teunissen, PhD (Amsterdam UMC)
Henrik Zetterberg, MD, PhD (University of Gothenburg)

2:10 –
3:20 pm

Lightning Round (15 min each; 10 min for Q&A)

Erez Eitan, PhD, MBA (NeuroDex)
Lampros Kourtis, PhD, MSc (SpeechDx)
Steven Krein, JD (StartUp Health)
Cecilia Lee, MD, MS (University of Washington)

3:20 –
3:30 pm

Closing Remarks

Morning Session

8:00 –
8:30 am

Breakfast/Poster Session

Registration Location:

Level 1 | Auditorium II

8:30 –
8:45 am

Opening Remarks

Niranjan Bose, PhD, MS, B Pharm (Gates Ventures)
Howard Fillit, MD (ADDF)
Mark Roithmayr (ADDF)

8:45 –
9:15 am

Keynote: Update on Blood-Based Biomarkers for Alzheimer's Disease

Henrik Zetterberg, MD, PhD (University of Gothenburg)

9:15 –
9:25 am

Overview of DxA Portfolio

Laura Nisenbaum, PhD, MS (ADDF)

9:25 –
10:10 am

Panel: The Future of Alzheimer's Diagnostics in Clinical Care

Moderator: Niranjan Bose, PhD, MS, B Pharm (Gates Ventures)

Panelists:
Nicholas Ashton, PhD (University of Gothenburg)
Rhoda Au, PhD, MBA (Boston University)
Joel Braunstein, MD, MBA (C2N)
Dilraj Grewal, MD (Duke University)
Joseph Volpe, PhD (Labcorp)
Howard Fillit, MD (ADDF)

10:10 –
10:25 am

Coffee Break

10:25 –
10:45 am

To pTau217, or (Not) to pTau181, That Is the Question

Manu Vandijck (Fujirebio Europe NV)

10:45 –
11:05 am

Clinical Implementation of the ALZpath pTau217 Test, ALZpath Dx

Andreas Jeromin, PhD (ALZPath)

11:05 –
11:25 am

Novel Blood-Based Mitochondrial Biomarkers for the Prognosis of Progression from MCI to Alzheimer's Disease

Marta Barrachina, PhD, MBA (ADmit Therapeutics)

11:25 –
12:25 pm

Networking Luncheon

Lunch will be served

Afternoon Session

12:25 –
12:45 pm

Validation of the ki:elements Speech Biomarker for Cognition (SB-C) in Alzheimer’s Disease

Nicklas Linz, PhD (ki:elements)

12:45 –
1:05 pm

Digitally-Driven Precision Medicine: Accurate Identification of Preclinical and Prodromal Alzheimer’s & Measuring the Progression of MCI

Mylea Charvat, PhD (Altoida)
Marc Jones, MS (Altoida)
Ioannis Tarnanas, PhD (Altoida)

1:05 –
1:25 pm

Smartphone-Based Learning and Memory Assessment: Assessing Community Engagement in the Lila App

Svenja Wacker, PhD (Cogstate)

1:25 –
2:10 pm

Panel: Methods and Standardization

Moderator: Robert Dean, MD, PhD (Dean Consulting)

Panelists:
Kaj Blennow, MD, PhD (University of Gothenburg)
Jeffrey Dage, PhD (Indiana University)
Charlotte Teunissen, PhD (Amsterdam UMC)
Henrik Zetterberg, MD, PhD (University of Gothenburg)

2:10 –
3:20 pm

Lightning Round (15 min each; 10 min for Q&A)

Erez Eitan, PhD, MBA (NeuroDex)
Lampros Kourtis, PhD, MSc (SpeechDx)
Steven Krein, JD (StartUp Health)
Cecilia Lee, MD, MS (University of Washington)

3:20 –
3:30 pm

Closing Remarks